Patent Rules

Marginal note:PCT sequence listing standard

• 58 (1) If a specification discloses a nucleotide sequence or amino acid sequence that must, in accordance with the PCT sequence listing standard, be included in a sequence listing and that is not identified as forming a part of the prior art, the description must contain the sequence listing in electronic form and both the electronic form and the content of the sequence listing must comply with the PCT sequence listing standard.

• Marginal note:One copy per application

  (2) An application for a patent must not contain more than one copy of a particular sequence listing regardless of its form of presentation.

• Marginal note:Statement — application originally filed without sequence listing

  (3) If an application for a patent originally filed without a sequence listing is amended to include one, the applicant must file a statement that the listing does not go beyond the disclosure in the application as filed.

• Marginal note:Sequence identification number

  (4) If a sequence included in a sequence listing is referred to in the claims, the drawings or the part of the description other than sequence listings, the reference must include the sequence identification number, as defined in the PCT sequence listing standard, preceded by “SEQ ID NO:”.

• Marginal note:Definitions

  (5) The following definitions apply in this section.

  amino acid sequence

  amino acid sequence has the same meaning as in the PCT sequence listing standard. (séquence d’acides aminés)

  nucleotide sequence

  nucleotide sequence has the same meaning as in the PCT sequence listing standard. (séquence de nucléotides)